Page last updated: 2024-08-21

oxazoles and Diffuse Large B-Cell Lymphoma

oxazoles has been researched along with Diffuse Large B-Cell Lymphoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, X; Ding, W; Jiang, L; Liu, A; Liu, J; Shi, X; Wen, C; Zhang, H; Zhou, H1
Larrick, JW; Torti, FM; Wright, SC; Zheng, H; Zhong, J1
Wright, SC; Zheng, H; Zhong, J1
Bergeron, R; Honeysett, JM; Taetle, R1

Other Studies

4 other study(ies) available for oxazoles and Diffuse Large B-Cell Lymphoma

ArticleYear
Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells.
    Cancer biology & therapy, 2022, 12-31, Volume: 23, Issue:1

    Topics: Animals; Apoptosis; Cyclin-Dependent Kinases; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Nude; Neoplasm Recurrence, Local; Oxazoles; Thiazoles

2022
Role of protein phosphorylation in TNF-induced apoptosis: phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF-resistant U937 variants.
    Journal of cellular biochemistry, 1993, Volume: 53, Issue:3

    Topics: Alkaloids; Apoptosis; Breast Neoplasms; Carbazoles; DNA; Drug Synergism; Ethers, Cyclic; Humans; Indoles; Lymphoma, Large B-Cell, Diffuse; Male; Marine Toxins; Okadaic Acid; Oxazoles; Phosphoproteins; Phosphoric Monoester Hydrolases; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1993
Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24).
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1996, Volume: 10, Issue:2

    Topics: Apoptosis; DNA; Enzyme Activation; Ethers, Cyclic; Humans; Lymphoma, Large B-Cell, Diffuse; Marine Toxins; Okadaic Acid; Oxazoles; Serine Endopeptidases; Sphingomyelin Phosphodiesterase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Ultraviolet Rays

1996
Combination iron depletion therapy.
    Journal of the National Cancer Institute, 1989, Aug-16, Volume: 81, Issue:16

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chelating Agents; Drug Screening Assays, Antitumor; Female; Gallium; Granulocytes; Hematopoietic Stem Cells; Humans; Immunoglobulin A; Iron Deficiencies; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Macrophages; Ovarian Neoplasms; Oxazoles; Receptors, Transferrin; Tumor Cells, Cultured

1989